SurgePays, Inc. (NASDAQ:SURG – Get Free Report) saw a large growth in short interest during the month of December. As of December 31st, there was short interest totaling 277,587 shares, a growth of 41.0% from the December 15th total of 196,892 shares. Currently, 1.9% of the shares of the company are sold short. Based on an average daily trading volume, of 168,232 shares, the days-to-cover ratio is currently 1.7 days. Based on an average daily trading volume, of 168,232 shares, the days-to-cover ratio is currently 1.7 days. Currently, 1.9% of the shares of the company are sold short.
Analyst Upgrades and Downgrades
A number of equities analysts have recently commented on the company. Ascendiant Capital Markets raised their price target on SurgePays from $9.50 to $9.75 and gave the stock a “buy” rating in a report on Monday, December 22nd. Wall Street Zen upgraded SurgePays to a “sell” rating in a research note on Saturday, January 3rd. Finally, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of SurgePays in a report on Monday, December 29th. One investment analyst has rated the stock with a Buy rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, SurgePays presently has an average rating of “Hold” and an average price target of $9.75.
Get Our Latest Stock Report on SURG
Insiders Place Their Bets
Hedge Funds Weigh In On SurgePays
Several institutional investors and hedge funds have recently bought and sold shares of SURG. James Investment Research Inc. lifted its position in SurgePays by 46.2% in the second quarter. James Investment Research Inc. now owns 19,000 shares of the medical equipment provider’s stock valued at $59,000 after purchasing an additional 6,000 shares during the last quarter. NewEdge Advisors LLC raised its holdings in SurgePays by 46.2% during the 2nd quarter. NewEdge Advisors LLC now owns 19,000 shares of the medical equipment provider’s stock valued at $59,000 after buying an additional 6,000 shares during the last quarter. Jane Street Group LLC purchased a new stake in SurgePays during the 2nd quarter valued at $42,000. Gerber LLC bought a new stake in SurgePays in the 3rd quarter worth $38,000. Finally, Goldman Sachs Group Inc. purchased a new position in shares of SurgePays in the first quarter valued at about $28,000. 6.94% of the stock is currently owned by institutional investors.
SurgePays Price Performance
Shares of SURG stock traded down $0.06 during trading on Friday, hitting $1.90. The company had a trading volume of 64,203 shares, compared to its average volume of 115,038. The company has a quick ratio of 0.41, a current ratio of 0.52 and a debt-to-equity ratio of 101.87. SurgePays has a 52 week low of $1.05 and a 52 week high of $3.47. The stock has a market capitalization of $39.98 million, a price-to-earnings ratio of -0.89, a price-to-earnings-growth ratio of 0.63 and a beta of 0.46. The stock’s 50-day moving average is $1.85 and its two-hundred day moving average is $2.47.
SurgePays (NASDAQ:SURG – Get Free Report) last posted its quarterly earnings data on Wednesday, November 12th. The medical equipment provider reported ($0.38) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.17) by ($0.21). SurgePays had a negative return on equity of 967.32% and a negative net margin of 83.42%.The firm had revenue of $18.68 million during the quarter, compared to analysts’ expectations of $18.12 million. As a group, analysts predict that SurgePays will post -1.66 EPS for the current fiscal year.
SurgePays Company Profile
SurgePays, Inc, together with its subsidiaries, operates as a financial technology and telecom company in the United States. It operates through three segments: Mobile Virtual Network Operators, Comprehensive Platform Services, and Lead Generation. The company offers subsidized and non-subsidized mobile virtual network operators for internet connectivity through mobile broadband services to consumers; ACH banking relationships and fintech transactions platform to convenience stores; wireless top-up transactions and wireless product aggregation; and lead generation and case management solutions primarily to law firms in the mass tort industry, as well as call center activities.
Read More
- Five stocks we like better than SurgePays
- Do not delete, read immediately
- How a Family Trust May Be Able To Help Preserve Your Wealth
- The Crash Has Already Started (Most Just Don’t See It Yet)
- Wall Street Alert: Buy AES
- Trump Planning to Use Public Law 63-43: Prepare Now
Receive News & Ratings for SurgePays Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SurgePays and related companies with MarketBeat.com's FREE daily email newsletter.
